BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Salvadori M, Rosso G, Bertoni E. Complement involvement in kidney diseases: From physiopathology to therapeutical targeting. World J Nephrol 2015; 4(2): 169-184 [PMID: 25949931 DOI: 10.5527/wjn.v4.i2.169]
URL: https://www.wjgnet.com/2220-6124/full/v4/i2/169.htm
Number Citing Articles
1
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney DiseaseInternational Journal of Molecular Sciences 2019; 20(21): 5517 doi: 10.3390/ijms20215517
2
Wai Han Yiu, Rui Xi Li, Dickson W L Wong, Hao Jia Wu, Kam Wa Chan, Loretta Y Y Chan, Joseph C K Leung, Kar Neng Lai, Steven H Sacks, Wuding Zhou, Sydney C W Tang. Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathyNephrology Dialysis Transplantation 2018; 33(8): 1323 doi: 10.1093/ndt/gfx336
3
Sandra Wymann, Yun Dai, Anup G. Nair, Helen Cao, Glenn A. Powers, Anna Schnell, Genevieve Martin-Roussety, David Leong, Jason Simmonds, Kim G. Lieu, Mitchell J. de Souza, Marcel Mischnik, Shirley Taylor, Saw Yen Ow, Martin Spycher, Rebecca E. Butcher, Martin Pearse, Adrian W. Zuercher, Adriana Baz Morelli, Con Panousis, Michael J. Wilson, Tony Rowe, Matthew P. Hardy. A novel soluble complement receptor 1 fragment with enhanced therapeutic potentialJournal of Biological Chemistry 2021; 296: 100200 doi: 10.1074/jbc.RA120.016127
4
Louise Oni. Paediatric immune-mediated renal disease: an overviewNephrology Dialysis Transplantation 2021; 36(4): 596 doi: 10.1093/ndt/gfz184
5
Wolfgang Winnicki, Peter Pichler, Karl Mechtler, Richard Imre, Ines Steinmacher, Gürkan Sengölge, Daniela Knafl, Georg Beilhack, Ludwig Wagner. A novel approach to immunoapheresis of C3a/C3 and proteomic identification of associatesPeerJ 2019; 7: e8218 doi: 10.7717/peerj.8218
6
Maurizio Salvadori, Giuseppina Rosso. Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNWorld Journal of Nephrology 2016; 5(4): 308-320 doi: 10.5527/wjn.v5.i4.308
7
C Wehling, O Amon, M Bommer, B Hoppe, K Kentouche, G Schalk, R Weimer, M Wiesener, B Hohenstein, B Tönshoff, R Büscher, H Fehrenbach, Ö-N Gök, M Kirschfink. Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disordersClinical and Experimental Immunology 2017; 187(2): 304 doi: 10.1111/cei.12890
8
Antonio Mastrangelo, Jessica Serafinelli, Marisa Giani, Giovanni Montini. Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in ChildhoodFrontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00205
9
Margarita Semis, Gabriel B. Gugiu, Ellen A. Bernstein, Kenneth E. Bernstein, Markus Kalkum. The Plethora of Angiotensin-Converting Enzyme-Processed Peptides in Mouse PlasmaAnalytical Chemistry 2019; 91(10): 6440 doi: 10.1021/acs.analchem.8b03828
10
Sebastian Weiss, Alva Rosendahl, Daniel Czesla, Catherine Meyer-Schwesinger, Rolf A. K. Stahl, Heimo Ehmke, Christian Kurts, Peter F. Zipfel, Jörg Köhl, Ulrich O. Wenzel. The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertensionAmerican Journal of Physiology-Renal Physiology 2016; 310(11): F1356 doi: 10.1152/ajprenal.00040.2016
11
Morten Schøler Fast, Kathrin Weyer, Henrik Pedersen, Gregers Rom Andersen, Henrik Birn. Filtration and tubular handling of EWE‐hC3Nb1, a complement inhibitor nanobody, in wild type mice and a mouse model of proteinuric kidney diseaseFEBS Open Bio 2024; 14(2): 322 doi: 10.1002/2211-5463.13752
12
David Cucchiari, Manuel Alfredo Podestà, Claudio Ponticelli. The Critical Role of Innate Immunity in Kidney TransplantationNephron 2016; 132(3): 227 doi: 10.1159/000444267
13
Marion Anliker-Ort, Jasper Dingemanse, John van den Anker, Priska Kaufmann. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement PathwayFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.599417
14
Marlies Bode, Jan Niklas Diemer, The Vinh Luu, Nikolas Ehnert, Teresa Teigeler, Thorsten Wiech, Maja T. Lindenmeyer, Georg R. Herrnstadt, Jasmin Bülow, Tobias B. Huber, Nicola M. Tomas, Ulrich O. Wenzel. Complement component C3 as a new target to lower albuminuria in hypertensive kidney diseaseBritish Journal of Pharmacology 2023; 180(18): 2412 doi: 10.1111/bph.16097